Location: Home
  • search
  • go
  • Relate News
  • 8/12/2022Zai Lab Throws the Towel in CD47 Race and Decides to 'Deprioritize' I...
  • 8/12/2022Janssen Licences TESSA Technology from WuXi ATU
  • 8/12/2022NMPA Issues Announcement for Applicability of ICH Guidelines E8(R1) an...
  • 8/12/2022Drug R&D and Product Registration News Digest August 2022 (2)
  • 8/12/2022Recent Official and Executive Moves
  • 8/11/2022NMPA Orders to Strengthen Routine Regulation of Drug Clinical Trial In...
  • 8/11/2022Snapshot of BMI System Financial Performance in H1/2022
  • 8/11/2022Snapshot of Ten Best-Selling Drugs in Retail Pharmacies Q2/2022
  • 8/11/2022IQVIA: Overall Chinese Pharma Market Up 8.3% in 2021
  • 8/11/2022DuPont to Add Biopharma Silicone Tubing Plant in China
  • 8/10/2022Central Government Issues Notice on Strengthening Production, Reserve ...
  • 8/10/2022Chiesi Group Continues China Business Expansion: China Daily
  • 8/9/2022BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in ...
  • 8/9/2022NHSA Introduces the Uniform Coding Rules and Methods for BMI Designate...
  • 8/9/2022NHSA Cites Three Major Pharma Manufacturers for Artificially Hiking AP...
  • 8/9/2022CDE Solicits Comments on the Draft "Technical Guidelines for Implement...
  • 8/9/2022CDE Solicits Comments on the Draft "Technical Guidelines for Clinical ...
  • 8/9/2022CDE Solicits Comments on the Draft "Technical Guidelines for Benefit-R...
  • 8/9/2022Ophthalmology A New Opportunity for Biotechs in China (PharmaDJ)
  • 8/9/2022Analysis of Regulations for Approval of Digital Therapeutics in China
  • 8/8/2022Emerging Biopharma's Contribution to Innovation (IQVIA)
  • 8/8/2022Bayer's Xarelto Squeeze Rolls on As Cancer Newcomer Nubeqa Gains Steam
  • 8/8/2022Hansoh and TiumBio Enter $164M Licensing Pact for TU2670 in China
  • 8/8/2022AstraZeneca and Wuxi Biologics Tie Up to Make Preventive Covid-19 Jab ...
  • 8/8/2022Grand Pharma and XELTIS Enter Strategic Partnership for Endogenous Tis...
  • 8/5/2022CNIPA Rules In Favor of Boehringer in First Important Patent Infringem...
  • 8/5/2022More Than 30 Chinese Health Official Investigated/Prosecuted for Corru...
  • 8/5/2022Recent Executive Moves
  • 8/5/2022Drug R&D and Product Registration News Digest August 2022 (1)
  • 8/5/2022Bird's Eye View of Chinese Pharma Now: A Mixed Bag of Mostly Negative ...
  • Page:75/719 Total number of articles:21546: [First][<<] [73] [74] [75] [76] [77] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group